Fig. 1: Tet2KO HSPCs are dependent on DOT1L activity.

A Percentage of BFP−Tet2WT or BFP−Tet2KO HPCHOXB4 cells in competition with BFP+Tet2WT HPCHOXB4 cells at the indicated time points after starting the experiment. n = 3 experimental replicates. Unpaired t test used for significance. B The percentage of BFP−Tet2KO HPCHOXB4 cells after treatment with the indicated compounds or DMSO (highlighted in orange) for 14 days. The dashed line represents the percentage of Tet2KO HPCHOXB4 in DMSO treatment. Data represent the average of 3 experimental replicates. Representative data from one of 3 independent screens are shown. C Count of Annexin V negative Tet2KO or Tet2WT HPCHOXB4 cells treated with 1 μM of each compound over time normalized to the corresponding untreated sample. n = 3 experimental replicates. Unpaired t test with multiple testing corrections used for significance. D Percentage of Venus+Tet2WT or Venus+Tet2KO HPCHOXB4 cells in competition with Venus−Tet2WT HPCHOXB4 cells over time. Both cell types were transduced with the indicated shRNA vectors. n = 3 experimental replicates. Unpaired t test used for significance. E Proportion of CD45.2+Tet2KO or CD45.2+Tet2WT HSPCs in competition with CD45.1+Tet2WT HSPCs after treatment with DMSO or SGC0946 (SGC; 1 μM). Data are normalized to DMSO-treated CD45.2+Tet2WT cells. Unpaired t test used for significance. n = 3 experimental replicates. F Proportion of CD45.2+Tet2KO or CD45.2+Tet2WT HSPCs in competition with CD45.1+Tet2WT HSPCs gated on the transduced BFP+ population. Data are normalized to shNT-expressing CD45.2+Tet2WT cells. Unpaired t test used for significance. n = 3 experimental replicates. Data are shown as mean ± SEM. G Number of colonies formed in per 1 × 104 Lin-Kit+ (LK) HSPCs in the presence of DMSO or SGC0946 (SGC; 1 μM). n = 3 experimental replicates. Unpaired t test used for significance. All data shown are mean ± SD unless otherwise indicated. Asterisks indicate statistical significance. Source data are provided as a Source Data file.